Results 221 to 230 of about 14,990,726 (282)

Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [²²⁵Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs. [PDF]

J Nucl Med
Sgouros G, Ulaner GA, He B, Ghaly M, Frey E, Kotiah S, Scott A, Ferreira D, Sneeden E, Morris M.   +9 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma. [PDF]

ESMO Open
Babatunde OO, Seier K, Schwartz G, Keohan ML, D'Angelo SP, Gounder MM, Chi P, Antonescu CR, Landa J, Qin LX, Crago AM, Singer S, Koff A, Tap WD, Dickson MA.   +14 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Well-differentiated systemic mastocytosis: Genetics, mast cell immunophenotypes, and KIT autophosphorylation. [PDF]

J Allergy Clin Immunol
Schornack BJ, McMurray JC, Leondaridis M, Sun X, Stinson JR, James A, Brunader JA, Hartman KR, Villar J, Dalgard CL, Hellwig LD, Montebello AN, Engin Zerk P, Guarnieri AL, Zhou Y, Jalluri RK, Pryor EM, Snow AL, George TI, Carter MC, Maric I, Boggs NA.   +21 more
europepmc   +1 more source

Developing a diagnostic model to differentiate the well-differentiated lipomatous tumors based on clinicopathological characteristics. [PDF]

Sci Rep
Wu J, Zhang Z, Song F, Chen X, Huang S.
europepmc   +1 more source

Diagnostic challenges of rarely well-differentiated adenocarcinoma of the stomach. [PDF]

Pathol Oncol Res
Qin T, Wang Y, Xiao Z, Ma L, Fan C, Zhu C, Luo L, Zhang Q, Liu C.   +8 more
europepmc   +1 more source

Well-Differentiated Neuroendocrine Tumors of Lung: A Case Series Supporting the IARC/WHO Common Classification of Neuroendocrine Tumor Nomenclature and Grading. [PDF]

Endocr Pathol
Altun E, Savari O, Maravillas MA, Asa SL.   +3 more
europepmc   +1 more source

Complete Resection of Giant and Well-Differentiated Retroperitoneal Liposarcoma: A Case Report. [PDF]

Cureus
Zhang L, Zhang J, Chen B, Li Y, Hu Z.
europepmc   +1 more source